Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS088448, R01NS095954)
Article History
Received: 2 October 2023
Revised: 1 February 2024
Accepted: 2 February 2024
First Online: 25 March 2024
Declarations
:
: F.H. serves as a member of SAB of Muna Therapeutics and a consultant for Alector, Guidepoint, and GLG. Other authors have no competing interests.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. The work under animal protocol 2017-0056 is approved by the Institutional Animal Care and Use Committee at Cornell University.